British pharmaceuticals is generally represented as a successful secto
r which illustrates the potential of knowledge-intensive, high-value-a
dded activities. This article presents a revisionist account based on
evidence and argument. Pharmaceuticals is a small sector which combine
s high-value-added and average wages to benefit capital not labour. Th
e knowledge base in the laboratory creates imitative product with mark
eting then applied to capture social expenditure. When product-market
growth slows, the sector restructures defensively without solving its
problems.